UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

4CPS-108 Biomarkers evolution in patients with SARS-CoV-2 pneumonia treated with baricitinib

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A64-A65

2022

Volltextzugriff (PDF)

Reported occupational respiratory diseases in Catalonia

Occupational and environmental medicine (London, England), 2006-04, Vol.63 (4), p.255-260

2006

Volltextzugriff (PDF)

4CPS-078 Assessment of the quality of a hospital’s clinical trial initiation visit

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A49-A50

2023

Volltextzugriff (PDF)

4CPS-016 Predictive performance of glomerular filtration rate equations based on cystatin c, creatinine and their combination in critically ill patients

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A29-A29

2023

Volltextzugriff (PDF)

4CPS-004 Trends in treatments during COVID-19 pandemic in a university tertiary hospital

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A24-A24

2023

Volltextzugriff (PDF)

3PC-028 Formulation of an oral platelet lysate gel to treat chronic graft versus host disease associated oral mucositis: effectiveness in a series of cases

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A20-A21

2023

Volltextzugriff (PDF)

4CPS-006 Evaluation study of the change in administration timing of fixed combination: netupitant and palonosetron in oncohaematologic patients with high doses of carboplatin

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A29-A30

2022

Volltextzugriff (PDF)

4CPS-014 Comparison of two protocols for the administration of leucovorin rescues after high dose methotrexate infusion of 24 hours

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A28-A28

2023

Volltextzugriff (PDF)

Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06)

The lancet oncology, 2010-04, Vol.11 (4), p.350-357

2010

Volltextzugriff (PDF)

Occupational asthma in food packers

Archivos de bronconeumología, 2003-07, Vol.39 (7), p.324

2003

Volltextzugriff (PDF)

Asma ocupacional en envasadores de alimentos

Archivos de bronconeumología, 2003, Vol.39 (7), p.324-326

2003

Volltextzugriff (PDF)

Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients

Annals of oncology, 2017-06, Vol.28 (6), p.1325-1332

2017

Volltextzugriff (PDF)

Belimumab‐induced papular elastorrhexis: A case report

Australasian journal of dermatology, 2023-11, Vol.64 (4), p.e396-e399

2023

Volltextzugriff (PDF)

Predicting response and survival in chemotherapy-treated triple-negative breast cancer

British journal of cancer, 2014-10, Vol.111 (8), p.1532-1541

2014

Volltextzugriff (PDF)

NK Cell Infiltrates and HLA Class I Expression in Primary HER2 + Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival

Clinical cancer research, 2019-03, Vol.25 (5), p.1535-1545

2019

Volltextzugriff (PDF)

Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

Clinical & translational oncology, 2018-07, Vol.20 (7), p.815-826

2018

Volltextzugriff (PDF)

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study

Breast cancer research and treatment, 2012-11, Vol.136 (2), p.487-493

2012

Volltextzugriff (PDF)

Effect of legume flours on baking characteristics of gluten-free bread

Journal of cereal science, 2012-09, Vol.56 (2), p.476-481

2012

Volltextzugriff (PDF)

Treatment of Porokeratosis Ptychotropica With a Topical Combination of Cholesterol and Simvastatin

JAMA dermatology (Chicago, Ill.), 2023-04, Vol.159 (4), p.458

2023

Volltextzugriff (PDF)

Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER)

European journal of cancer (1990), 2022-01, Vol.161, p.26-37

2022

Volltextzugriff (PDF)

Phase II and Tumor Pharmacodynamic Study of Gefitinib in Patients with Advanced Breast Cancer

Journal of clinical oncology, 2005-08, Vol.23 (23), p.5323-5333

2005

Volltextzugriff (PDF)

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor Types

Journal of clinical oncology, 2002-11, Vol.20 (21), p.4292-4302

2002

Volltextzugriff (PDF)

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Journal of clinical oncology, 2012-05, Vol.30 (14), p.1594-1600

2012

Volltextzugriff (PDF)

Trastuzumab (herceptin), a humanized anti-HER2 receptor monoclonal antibody, inhibits basal and activated HER2 ectodomain cleavage in breast cancer cells

Cancer research (Chicago, Ill.), 2001-06, Vol.61 (12), p.4744-4749

2001

Volltextzugriff (PDF)

A High-Throughput Screening Identifies MicroRNA Inhibitors That Influence Neuronal Maintenance and/or Response to Oxidative Stress

Molecular therapy. Nucleic acids, 2019-09, Vol.17, p.374-387

2019

Volltextzugriff (PDF)

1 – 25 von 258

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(250)
Mit Volltextzugriff
(236)

Publikationsform

Artikel
(254)
Berichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(110)
Science & Technology
(110)
Humans
(98)
Female
(78)
Oncology
(76)
Biological And Medical Sciences
(57)
Middle Aged
(55)
Medical Sciences
(50)
Aged
(48)
Adult
(40)
Male
(36)
Tumors
(32)
Breast Neoplasms - Pathology
(30)
Breast Cancer
(26)
Breast Neoplasms - Drug Therapy
(24)
Pharmacology. Drug Treatments
(24)
Antineoplastic Agents
(22)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)
Prognosis
(19)
Chemotherapy
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

4CPS-108 Biomarkers evolution in patients with SARS-CoV-2 pneumonia treated with baricitinib

Reported occupational respiratory diseases in Catalonia

4CPS-078 Assessment of the quality of a hospital’s clinical trial initiation visit

4CPS-016 Predictive performance of glomerular filtration rate equations based on cystatin c, creatinine and their combination in critically ill patients

4CPS-004 Trends in treatments during COVID-19 pandemic in a university tertiary hospital

3PC-028 Formulation of an oral platelet lysate gel to treat chronic graft versus host disease associated oral mucositis: effectiveness in a series of cases

4CPS-006 Evaluation study of the change in administration timing of fixed combination: netupitant and palonosetron in oncohaematologic patients with high doses of carboplatin

4CPS-014 Comparison of two protocols for the administration of leucovorin rescues after high dose methotrexate infusion of 24 hours

Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06)

Occupational asthma in food packers

Asma ocupacional en envasadores de alimentos

Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients

Belimumab‐induced papular elastorrhexis: A case report

Predicting response and survival in chemotherapy-treated triple-negative breast cancer

NK Cell Infiltrates and HLA Class I Expression in Primary HER2 + Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival

Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study

Effect of legume flours on baking characteristics of gluten-free bread

Treatment of Porokeratosis Ptychotropica With a Topical Combination of Cholesterol and Simvastatin

Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER)

Phase II and Tumor Pharmacodynamic Study of Gefitinib in Patients with Advanced Breast Cancer

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor Types

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Trastuzumab (herceptin), a humanized anti-HER2 receptor monoclonal antibody, inhibits basal and activated HER2 ectodomain cleavage in breast cancer cells

A High-Throughput Screening Identifies MicroRNA Inhibitors That Influence Neuronal Maintenance and/or Response to Oxidative Stress

Suchergebnisse filtern